Drug Shortage Report for DUAVIVE
| Report ID | 114978 |
| Drug Identification Number | 02432854 |
| Brand name | DUAVIVE |
| Common or Proper name | Duavive |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | CONJUGATED ESTROGENS BAZEDOXIFENE |
| Strength(s) | 0.45MG 20MG |
| Dosage form(s) | TABLET (IMMEDIATE AND EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 28's blister |
| ATC code | G03CC |
| ATC description | ESTROGENS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-05-11 |
| Estimated end date | Unknown |
| Actual end date | 2023-06-09 |
| Shortage status | Resolved |
| Updated date | 2023-06-27 |
| Company comments | A more specific re-supply timeline will be provided as information becomes available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-05-13 | English | Compare |
| v2 | 2020-05-13 | French | Compare |
| v3 | 2020-07-03 | English | Compare |
| v4 | 2020-07-03 | French | Compare |
| v5 | 2020-07-23 | English | Compare |
| v6 | 2020-07-23 | French | Compare |
| v7 | 2020-08-21 | English | Compare |
| v8 | 2020-08-21 | French | Compare |
| v9 | 2020-09-08 | English | Compare |
| v10 | 2020-09-08 | English | Compare |
| v11 | 2020-09-08 | French | Compare |
| v12 | 2020-11-17 | English | Compare |
| v13 | 2020-11-17 | French | Compare |
| v14 | 2023-06-27 | English | Compare |
| v15 | 2023-06-27 | French | Compare |
Showing 1 to 15 of 15